Eris Lifesciences

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue775.69795.22807.47758.79875.64
Expenses615.48622.83645.00598.18695.75
EBITDA279.40291.02281.63275.80298.61
Operating Profit209.78222.22194.17205.03226.14
Profit Before Tax161.10172.67145.35159.41179.49
Net Profit125.10134.47108.83279.10143.32
Financial Ratios
Operating Profit Margin36.33%36.87%33.03%36.50%34.32%
Net Profit Margin15.29%15.21%14.06%37.43%16.38%
Earning Per Share (Diluted)8.648.817.3120.5710.26
Dividends Per Share0.000.000.000.000.00